ML18138A389

From kanterella
Jump to navigation Jump to search
Mo-99 Stakeholder Meeting: Update on Licensing Reviews Supporting Domestic Molybdenum-99 Production
ML18138A389
Person / Time
Issue date: 05/16/2018
From: Steven Lynch
Research and Test Reactors Licensing Projects Branch
To:
Lynch S, NRR/DLP, 415-1524
References
Download: ML18138A389 (8)


Text

National Nuclear Security Administration Mo-99 Stakeholders Meeting Update on Licensing Reviews Supporting Domestic Molybdenum-99 Production Office of Nuclear Reactor Regulation U.S. Nuclear Regulatory Commission May 16, 2018

Medical Isotope Licensing Reviews

  • Construction permit and operating license applications

Northwest Medical Isotopes (NWMI)

SHINE Medical Technologies (SHINE)

  • License amendment requests anticipated from Oregon State University (OSU) and University of Missouri Research Reactor Center (MURR) in support of NWMI project
  • Materials license, and subsequent amendments, issued to Niowave
  • Licensing guidance issued for NorthStar RadioGenix generator system 2
  • NWMI proposes to manufacture and process low enriched uranium (LEU) targets for 99Mo production in Columbia, Missouri

Target manufacturing to be licensed under Title 10 of the Code of Federal Regulations (10 CFR) Part 70

LEU targets irradiated at existing research reactors

Irradiated targets returned to NWMI for processing in a 10 CFR Part 50 production facility

  • NRC staff applied best practices to support 23-month review

Emphasis on most safety-significant technical aspects

Focused requests for additional information

Weekly status calls Northwest Medical Isotopes 3

  • Construction permit application submitted in 2015
  • Final environmental impact statement published in May 2017
  • Advisory Committee Meeting on Reactor Safeguards full committee meeting held in November 2017
  • Safety evaluation report completed in November 2017
  • Commission held mandatory hearing in January 2018

Staff and applicant presented on unique licensing considerations

  • Construction permit issued in May 2018 Status of NWMI Review 4

SHINE Medical Technologies, Inc.

  • SHINE proposes to fission LEU target solution in 8 irradiation units licensed as 10 CFR Part 50 utilization facilities
  • SHINE proposes to recover 99Mo by processing irradiated target solution in hot cells licensed as a 10 CFR Part 50 production facility
  • Construction permit issued in February 2016

Periodic reports on permit conditions

Annual financial reports

  • Pre-construction and pre-application meetings scheduled in April and May 2018

Construction expected to begin in 2018

Operating license application expected in 2018

Reactor License Amendments at MURR

  • First of two anticipated amendment requests related to General Atomics (GA) selective gas extraction (SGE) technology submitted in May 2017 If granted, would have allowed modification of reactor reflector and installation of supporting systems for LEU target irradiation Second amendment would have supported installation of SGE hot cells to process irradiated targets In an April 2018 press release, Nordion, Inc. announced withdrawal of support for medical isotope production project partnership with GA and MURR Consequently, GA terminated its contract with MURR, who subsequently withdrew its license amendment request to produce Mo-99 using the GA SGE process 6

Materials and Medical Use Licenses

  • Materials license issued to Niowave in 2015

Production of small amounts of 99Mo through uranium fission using superconducting linacs for proof of concept

NRC staff has issued amendments increasing LEU possession limit and supporting irradiation of natural uranium targets

  • NorthStar Medical Radioisotopes

Proposes to produce Mo-99 from molybdenum targets enriched in Mo-98

Developed RadioGenix Tc-99m generator system

NRC staff published licensing guidance for medical use applicants and licensees that possess RadioGenix system in February 2018

NRC staff currently considering updated information on generator system and potential changes to licensing guidance 7

Oversight, Infrastructure, and Support Activities

  • Developing construction and operation inspection programs

Construction inspection program established in December 2015

Inspections commensurate with risk of facility, focusing on most safety-significant structures, systems, and components

  • Updating regulatory framework

Published proposed rule to streamline license renewal in 2017

Supporting development of proposed rule for emergency planning

  • Coordinating technical and licensing expertise through inter-office working group
  • Providing updates on public website:

http://www.nrc.gov/reactors/medical-radioisotopes.html 8